Nurse Practitioner in Locust, NC Accepting Medicare
6 Nurse Practitioner nurses found. Showing 1 - 6
 Michael D Hinson, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 316 Wendover Dr, Locust, NC 28097 Phone: 704-791-2097 |
 Sierra George, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 130 James Ave, Locust, NC 28097 Phone: 704-271-3777 |
Keyeriashon Dugazon Tucker, F.N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 236 Market St Ste 110, Locust, NC 28097 Phone: 704-384-9590 |
Kristina Marie Wilson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 123 Professional Park Dr, Locust, NC 28097 Phone: 704-403-6760 |
Kathleen Marie Mishak, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 236 Market St Ste 110, Locust, NC 28097 Phone: 704-384-9590 |
Brianna Phares Parrott, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 130 James Ave, Locust, NC 28097 Phone: 704-271-3777 |
News Archive
Real-time data access can improve quality and efficiency of drug development
Technologies to capture and view clinical trial data in real time offer great potential to enhance patient safety, strengthen trial quality and accelerate drug development, but they also require new guidelines to ensure trial integrity, according to the white paper "Using Real-Time Data to Drive Better Decisions, Faster" released today by Quintiles, the world's leading biopharmaceutical services company.
Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia that has relapsed.
Medtronic highlights scientific sessions of interest on program for TCT 2011
Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. today highlighted scientific sessions of interest on the program for TCT 2011, which takes place Nov. 7-11 in San Francisco.
Crescendo Biologics successfully delivers triple knockout mice
Crescendo Biologics Limited today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.
› Verified 8 days ago